Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal endoxin and pregnancy complication.

R C Goodlin1

  • 1Department of Obstetrics & Gynecology, University of Colorado Health Sciences Center, Denver 80262.

American Journal of Obstetrics and Gynecology
|March 1, 1988
PubMed
Summary

Digoxin-like substances, or endoxin, increase in pregnant women. High endoxin levels may signal high-risk pregnancies and suggest therapies like nifedipine or antidigoxin serum.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fetal Heart Rate Response to Maternal Exercise Testing.

The Physician and sportsmedicine·2016
Same author

Is it time to move on?

American journal of obstetrics and gynecology·2001
Same author

Preeclampsia and fetal growth.

Obstetrics and gynecology·2001
Same author

Obstetrics for the new millennium.

American journal of obstetrics and gynecology·2001
Same author

Were there any misdiagnoses?

American journal of obstetrics and gynecology·2000
Same author

What is the meaning of authorship?

American journal of obstetrics and gynecology·2000

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Physiology
  • Endocrinology

Background:

  • Digoxin-like substances (endoxin) concentrations rise with pregnancy progression.
  • Elevated endoxin levels are observed in high-risk pregnancies, including those with hypertension or premature labor.

Purpose of the Study:

  • To investigate the role of endoxin in pregnancy.
  • To explore the potential of endoxin levels as a marker for high-risk pregnancies.
  • To identify potential therapeutic interventions for pregnancies with high endoxin levels.

Main Methods:

  • Serum and urine samples were collected from pregnant women.
  • Endoxin concentrations were measured in these samples.
  • Correlation between endoxin levels and pregnancy complications was analyzed.

Main Results:

  • Endoxin concentrations increase with advancing pregnancy.
  • Higher endoxin levels were found in women with hypertension and/or premature labor.
  • Urinary endoxin levels may indicate unsuspected high-risk pregnancies.

Conclusions:

  • Endoxin levels are a potential biomarker for identifying high-risk pregnancies.
  • Nifedipine and antidigoxin serum are proposed as therapies for abnormal pregnancies with high endoxin.
  • Monitoring urinary endoxin may aid in early detection of high-risk pregnancies.

Related Experiment Videos